MVM. N. Valiakhmetov

M. N. Valiakhmetov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


M. N. Valiakhmetov has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Сomorbidities, risk factors and causes of death in patients with myocardial infarction of different prescription, based on follow-up after hospitalization at a multidisciplinary center

    by M. M. Luk'YAnov, T. A. Gomova, R. N. Shepel, E. Yu. Okshina, E. Yu. Andreenko, A. A. Smirnov, N. N. Kuzina, A. G. Soplenkova, E. V. Stepanova, M. N. Valiakhmetov, et al.

    Aim. To analyze multimorbidity, risk factors for death, its incidence, and causes, based on long-term follow-up after hospitalization at a multidisciplinary center for acute myocardial infarction (MI) or other pathologies associated with old myocardial infarction. Material and methods. The SOFIT registry included 855 patients treated for acute MI and 1341 patients treated for other pathologies associated with old MI (age (M±SD) — 64,1±12,1 and 65,8±10,9 years; men — 65,6% and 69,7%). The median [interquartile range] follow-up duration was 2,6 [2,2; 2,9] years. Results. Multimorbidity in the comparison groups was recorded in 97,1 and 94,8% of cases (p=0,01), while cardiovascular multimorbidity — in 95,4 and 86,1% (pConclusion. Patients after myocardial infarction (MI), regardless of its duration, are characterized by a high death risk due to comorbid pathology, which is significantly reduced by appropriate combination cardiovascular pharmacotherapy.

  • Multimorbidity, risk factors and causes of death in patients with cardiovascular diseases during long-term posthospital monitoring

    by M.M. Loukianov, T.A. Gomova, Shepel, E.Yu. Andreenko, E.Yu. Okshina, N.N. Kuzina, A.G. Soplenkova, E.V. Stepanova, M.N. Valiakhmetov, A.A. Savishceva, et al.

    Objective. To conduct a comparative analysis of the frequency, causes, and risk factors of death in patients with cardiovascular diseases according to long-term follow-up after hospitalization in various departments of a multifaceted hospital. Materials and methods. Multimorbidity, history of coronavirus infection (COVID-19), frequency, causes, and risk factors of death during the follow-up period of 2.6 [2.3; 2.8] years were assessed in 13/551 patients with cardiovascular diseases (CVD) after discharge from the various departments in the proSpective registry Of a multiFaceted medIcal cenTer (SOFIT). Results. Two or more CVDs and non-cardiac diseases were reported in 81.4% of cases, cardiovascular multimorbidity in 47.5%, non-cardiac multimorbidity in 52.4%, and their combination in 17.9% of patients. 15.5% of patients died. On average, the highest mortality per year was reported in patients discharged from the emergency cardiology department (9.0%), the lowest from the cardiology department (4.4%), and from the departments of therapeutic and other profiles — 5.6 and 6.6%, respectively. The proportion of deaths from cardiovascular causes among deceased patients with CVD was 35.8%. The mortality risk was associated with age and male sex, increased by 1.2—1.7 times in the presence of a history of myocardial infarction, cerebrovascular accident, diabetes mellitus, chronic obstructive pulmonary disease, or inpatient treatment for COVID-19. The COVID-19-related mortality risk increased with age, and was several times lower in patients with a history of previous outpatient and inpatient treatment for this disease (8.2 and 4.9 times). Conclusion. In patients with cardiovascular diseases, monitored in the long-term follow-up after treatment in a multifaceted hospital, multimorbidity was reported in 81.4% of cases, both cardiovascular and non-cardiac multimorbidity in about 50% of cases, and their combination in 17.9% of patients. 15.5% of patients died. The mean proportion of deaths per year was the highest among those discharged from the emergency cardiology department (9.0%), and the lowest from the cardiology department (4.4%). Cardiovascular causes of death were reported in a minority of deceased cardiovascular patients due to non-cardiac comorbidity. The risk of death from all and cardiovascular causes was associated with age, male sex, previous myocardial infarction, cerebrovascular accident, diabetes mellitus, chronic obstructive pulmonary disease, and a history of inpatient treatment for COVID-19. In patients with cardiovascular diseases, the higher risk of COVID-19-related mortality associated with age was several times lower in those with a history of the disease.

  • Open Access

    Patients with atrial fibrillation after discharge from a multidisciplinary hospital: analysis of death risk and its causes based on 10-year follow-up data

    by M. M. Luk'YAnov, T. A. Gomova, S. Yu. Martsevich, R. N. Shepel, A. G. Soplenkova, A. A. Smirnov, M. N. Valiakhmetov, E. V. Stepanova, A. A. Savishcheva, O. M. Drapkina, et al.

    Aim. To evaluate the outcomes of 10-year follow-up of patients with atrial fibrillation (AF) after hospitalization in various departments of a multidisciplinary hospital and to determine the most significant prognostic factors associated with a high death risk. Material and methods . In the outpatient registry RECVAZA-AF Tula after discharge from a multidisciplinary hospital, the outcomes for the period 2013-2024 (follow-up, 7,9±3,7 years) were assessed in 1159 patients with AF (age, 69,2±9,8 years; men, 48,0%). Information on fatal outcomes was obtained from the Regional Information System of the Tula Oblast. Results . Over 10 years, 509 (43,9%) patients with AF died. The highest proportion of deaths was among those who had stroke and myocardial infarction (MI) — 55,1 and 52,9%, respectively, with permanent AF (51,4%), at the age of ≥80 years (66,4%). High all-cause and cardiovascular death risk was associated with the following factors: age (hazard ratio (HR)=1,04 and HR=1,06; pConclusion . Over 10 years after discharge from a multidisciplinary hospital, 43,9% of patients with AF died. The mortality rate was highest in AF with prior stroke and MI, with permanent AF, and at an age of ≥80 years. Prognostically unfavorable factors also included diabetes, chronic obstructive pulmonary disease, low hemoglobin levels, and systolic blood pressure <110 mm Hg. The lowest mortality rate was among patients discharged from cardiology (excluding emergency cardiology) and internal medicine departments, and the highest one was among those discharged from emergency cardiology, neurology, and surgery departments.


  • Open Access

    Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes

    by M. M. Loukianov, S. Yu. Martsevich, Yu. V. Mareev, S. S. Yakushin, E. Yu. Andreenko, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, E. Yu. Okshina, Vl. Vl. Yakusevich, et al.

    Aim. To assess in clinical practice the structure of multimorbidity, cardiovascular pharmacotherapy and outcomes in patients with a combination of atrial fibrillation (AF) and chronic heart failure (CHF) based on prospective registries of patients with cardiovascular diseases (CVD).Materials and Methods. The data of 3795 patients with atrial fibrillation (AF) were analyzed within the registries RECVASA (Ryazan), RECVASA FP (Moscow, Kursk, Tula, Yaroslavl), REGION-PO and REGION-LD (Ryazan), REGION-Moscow, REGATA (Ryazan). The comparison groups consisted of 3016 (79.5%) patients with AF in combination with CHF and 779 (29.5%) patients with AF without CHF. The duration of prospective observation is from 2 to 6 years.Results. Patients with a combination of AF and CHF (n=3016, age was 72.0±10.3 years; 41.8% of men) compared with patients with AF without CHF (n=779, age was 70.3±12.0 years; 43.5% of men) had a higher risk of thromboembolic complications (CHA2DS2-VASc – 4.68±1.59 and 3.10±1.50; pConclusion. Patients with a combination of AF and CHF, compared with the group of patients with AF without CHF, were older, had a higher risk of thromboembolic and hemorrhagic complications, they were more often diagnosed with other concomitant cardiovascular and chronic noncardiac diseases, decreased left ventricular ejection fraction, tachysystole, failure to achieve the target blood pressure level in the presence of arterial hypertension. The frequency of prescribing proper cardiovascular pharmacotherapy was higher, albeit insufficient, in the presence of CHF, while the frequency of prescribing anticoagulants was less. The incidence of mortality from all causes, the development of non-fatal myocardial infarction and cerebral stroke, as well as the incidence of hospitalizations for CVDs were higher in AF associated with CHF.


  • Open Access

    Combination of Atrial Fibrillation and Coronary Heart Disease in Patients in Clinical Practice: Comorbidities, Pharmacotherapy and Outcomes (Data from the REСVASA Registries)

    by M. M. Loukianov, S. Yu. Martsevich, E. Yu. Andrenko, S. S. Yakushin, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, Е. Yu. Okshina, Vl. Vl. Yakusevich, E. M. Pozdnyakova, et al.

    Aim. Assess the structure of comorbid conditions, cardiovascular pharmacotherapy and outcomes in patients with atrial fibrillation (AF) and concomitant coronary artery disease (CAD) included in the outpatient and hospital RECVASA registries.Materials and methods. 3169 patients with AF were enrolled in outpatient RECVASA (Ryazan), RECVASA AF-Yaroslavl registries and hospital RECVASA AF (Moscow, Kursk, Tula). 2497 (78.8%) registries of patients with AF had CAD and 703 (28.2%) of them had a previous myocardial infarction (MI).Results. There were 2,497 patients with a combination of AF and CAD (age was 72.2±9.9 years; 43.1% of men; CHA2DS2-VASc – 4.57±1.61 points; HAS-BLED – 1.60±0,75 points), and the group with AF without CAD included 672 patients (age was 66.0±12.3 years; 43.2% of men; CHA2DS2-VASc – 3.26±1.67 points; HAS-BLED – 1,11±0.74 points). Patients with CAD were on average 6.2 years older and had a higher risk of thromboembolic and hemorrhagic complications (pConclusion. 78.8% of patients from AF registries in 5 regions of Russia were diagnosed with CAD, of which 28.2% had previously suffered myocardial infarction. Patients with a combination of AF and CAD more often than in the absence of CAD had hypertension, chronic heart failure, diabetes, chronic kidney disease and anemia. Patients with the previous MI had higher incidence of diabetes than those without the previous MI. The frequency of proper cardiovascular pharmacotherapy was insufficient, and to a greater extent in the presence of CAD and the previous MI than in their absence. All-cause mortality was recorded in patients with a combination of AF and CAD more often than in the absence of CAD. All-cause mortality and the incidence of nonfatal myocardial infarction were higher in patients with AF and the previous MI than in those without the previous MI. The presence of CAD and, in particular, the previous MI, was significantly associated with a higher risk of death, as well as a higher risk of developing a combined cardiovascular endpoint.